Menu
Recruiting NCT07602452

Bilateral Erector Spinae Plane Block Versus Bilateral Oblique Subcostal Transversus Abdominis Plane Block for Postoperative Analgesia in Colorectal Surgery

No phase Interventional Bilateral Erector Spinae Plane Block Bilateral Oblique Subcostal Transversus Abdominis Plane Block Postoperative Analgesia Colorectal Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Erector Spinae Plane Block, Oblique Subcostal Transversus Abdominis Plane Block.
Who it may be relevant to
Registry conditions: Bilateral Erector Spinae Plane Block, Bilateral Oblique Subcostal Transversus Abdominis Plane Block, Postoperative Analgesia, Colorectal Surgery. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Ultrasound-Guided Bilateral Erector Spinae Plane Block Versus Bilateral Oblique Subcostal Transversus Abdominis Plane Block for Postoperative Analgesia in Colorectal Surgery: A Prospective Randomized Study.

Overview

This study aims to compare the ultrasound-guided bilateral erector spinae plane block (ESPB) and oblique subcostal transverse abdominal plane block (OSTAPB) for postoperative analgesia in colorectal surgery.

Detailed description

Colorectal surgery remains the therapeutic cornerstone for the management of a wide variety of gastrointestinal disorders encompassing malignancies and inflammatory conditions.

Oblique subcostal transverse abdominal plane block (OSTAPB) is a regional block technique that involves injecting local anesthetics between the transverse abdominal muscle plane and the internal oblique abdominal muscle plane.

Ultrasound-guided erector spinae plane block (ESPB) is a novel technique that specifically targets the ventral rami, dorsal rami, and rami communicantes of the spinal nerves. Local anesthetic agents were observed to extend cranially and caudally over numerous dermatomal levels following injection.

Interventions

  • Other Erector Spinae Plane Block
    Patients will receive ultrasound-guided erector spinae plane block.
  • Other Oblique Subcostal Transversus Abdominis Plane Block
    Patients will receive ultrasound-guided oblique subcostal transversus abdominis plane block.

Primary outcome measures

  • Degree of pain [Time frame: 24 hours postoperatively]
Secondary outcome measures (8)
  • Time to the first rescue analgesia [Time frame: 24 hours postoperatively]
  • Intraoperative fentanyl consumption [Time frame: Intraoperatively]
  • Total morphine consumption [Time frame: 24 hours postoperatively]
  • Mean arterial pressure [Time frame: Till end of surgery (Up to 2 hours)]
  • Heart rate [Time frame: Till end of surgery (Up to 2 hours)]
  • Degree of patient satisfaction [Time frame: 24 hours postoperatively]
  • Quality of Recovery [Time frame: 24 hours postoperatively]
  • Incidence of adverse events [Time frame: 24 hours postoperatively]

Eligibility criteria

Inclusion criteria

  • Age 18 to 75 years old.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status II-III.
  • Scheduled for open colorectal surgery under general anesthesia.

Exclusion criteria

  • History of opioid abuse.
  • Chronic opioid consumption.
  • Body mass index (BMI) ≥ 35 kg/m2.
  • Severe cardiac insufficiency, defined as New York Heart Association (NYHA) class III or IV heart failure.
  • Renal failure, defined as an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m².
  • Hepatic encephalopathy.
  • Having a skin infection at or near the puncture site.
  • Coagulopathy, defined as platelet count < 100,000/mm³, INR > 1.5, or use of anticoagulant therapy that could not be withheld.
  • Allergy to drugs used in the study.
  • History of previous or recurrent laparoscopic cholecystectomy procedures.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Cairo

Identifiers

NCT: NCT07602452 · MD-316-2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗